Logo image of INL.DE

INTEL CORP (INL.DE) Stock Fundamental Analysis

Europe - FRA:INL - US4581401001 - Common Stock

30.02 EUR
+1.58 (+5.56%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

2

INL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 57 industry peers in the Semiconductors & Semiconductor Equipment industry. INL has a bad profitability rating. Also its financial health evaluation is rather negative. INL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

INL had positive earnings in the past year.
INL had a positive operating cash flow in the past year.
INL had positive earnings in 4 of the past 5 years.
In the past 5 years INL always reported a positive cash flow from operatings.
INL.DE Yearly Net Income VS EBIT VS OCF VS FCFINL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B

1.2 Ratios

The Return On Assets of INL (-10.65%) is worse than 87.72% of its industry peers.
INL has a worse Return On Equity (-20.95%) than 87.72% of its industry peers.
Industry RankSector Rank
ROA -10.65%
ROE -20.95%
ROIC N/A
ROA(3y)-1.42%
ROA(5y)4.24%
ROE(3y)-3.13%
ROE(5y)7.44%
ROIC(3y)N/A
ROIC(5y)N/A
INL.DE Yearly ROA, ROE, ROICINL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With a Gross Margin value of 29.76%, INL is not doing good in the industry: 89.47% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of INL has declined.
The Profit Margin and Operating Margin are not available for INL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.17%
GM growth 5Y-11.02%
INL.DE Yearly Profit, Operating, Gross MarginsINL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

INL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INL has more shares outstanding
INL has more shares outstanding than it did 5 years ago.
INL has a better debt/assets ratio than last year.
INL.DE Yearly Shares OutstandingINL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
INL.DE Yearly Total Debt VS Total AssetsINL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

INL has an Altman-Z score of 1.57. This is a bad value and indicates that INL is not financially healthy and even has some risk of bankruptcy.
INL has a Altman-Z score of 1.57. This is in the lower half of the industry: INL underperforms 78.95% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that INL is not too dependend on debt financing.
INL has a Debt to Equity ratio of 0.47. This is in the lower half of the industry: INL underperforms 70.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z 1.57
ROIC/WACCN/A
WACC10.24%
INL.DE Yearly LT Debt VS Equity VS FCFINL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

INL has a Current Ratio of 1.24. This is a normal value and indicates that INL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.24, INL is doing worse than 89.47% of the companies in the same industry.
A Quick Ratio of 0.92 indicates that INL may have some problems paying its short term obligations.
INL has a worse Quick ratio (0.92) than 78.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.92
INL.DE Yearly Current Assets VS Current LiabilitesINL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

3

3. Growth

3.1 Past

INL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.91%.
Measured over the past years, INL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -36.62% on average per year.
Looking at the last year, INL shows a decrease in Revenue. The Revenue has decreased by -3.72% in the last year.
Measured over the past years, INL shows a decrease in Revenue. The Revenue has been decreasing by -5.90% on average per year.
EPS 1Y (TTM)-53.91%
EPS 3Y-54.95%
EPS 5Y-36.62%
EPS Q2Q%400%
Revenue 1Y (TTM)-3.72%
Revenue growth 3Y-12.41%
Revenue growth 5Y-5.9%
Sales Q2Q%0.2%

3.2 Future

INL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.29% yearly.
Based on estimates for the next years, INL will show a small growth in Revenue. The Revenue will grow by 4.51% on average per year.
EPS Next Y-73.98%
EPS Next 2Y15.21%
EPS Next 3Y36.39%
EPS Next 5Y41.29%
Revenue Next Year-1.21%
Revenue Next 2Y1.04%
Revenue Next 3Y2.22%
Revenue Next 5Y4.51%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INL.DE Yearly Revenue VS EstimatesINL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
INL.DE Yearly EPS VS EstimatesINL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3 4 5

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 66.71, INL can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of INL indicates a rather expensive valuation: INL more expensive than 84.21% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.32. INL is valued rather expensively when compared to this.
INL is valuated quite expensively with a Price/Forward Earnings ratio of 53.10.
Based on the Price/Forward Earnings ratio, INL is valued expensively inside the industry as 84.21% of the companies are valued cheaper.
INL's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.89.
Industry RankSector Rank
PE 66.71
Fwd PE 53.1
INL.DE Price Earnings VS Forward Price EarningsINL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

INL's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.77
INL.DE Per share dataINL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

INL's earnings are expected to grow with 36.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.21%
EPS Next 3Y36.39%

0

5. Dividend

5.1 Amount

No dividends for INL!.
Industry RankSector Rank
Dividend Yield N/A

INTEL CORP

FRA:INL (9/26/2025, 7:00:00 PM)

30.02

+1.58 (+5.56%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners67.73%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap140.20B
Analysts58.04
Price Target18.91 (-37.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.32
Dividend Growth(5Y)-21.66%
DP-2.61%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1282.57%
Min EPS beat(2)725.25%
Max EPS beat(2)1839.89%
EPS beat(4)4
Avg EPS beat(4)869.45%
Min EPS beat(4)2.81%
Max EPS beat(4)1839.89%
EPS beat(8)7
Avg EPS beat(8)441.11%
EPS beat(12)10
Avg EPS beat(12)342.03%
EPS beat(16)13
Avg EPS beat(16)257.53%
Revenue beat(2)2
Avg Revenue beat(2)3.37%
Min Revenue beat(2)0.96%
Max Revenue beat(2)5.79%
Revenue beat(4)4
Avg Revenue beat(4)2%
Min Revenue beat(4)0.02%
Max Revenue beat(4)5.79%
Revenue beat(8)5
Avg Revenue beat(8)0.62%
Revenue beat(12)7
Avg Revenue beat(12)0.62%
Revenue beat(16)9
Avg Revenue beat(16)0.16%
PT rev (1m)-1.81%
PT rev (3m)1.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-83.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-57.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.91%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)2.97%
Valuation
Industry RankSector Rank
PE 66.71
Fwd PE 53.1
P/S 3.1
P/FCF N/A
P/OCF 16.32
P/B 1.68
P/tB 2.32
EV/EBITDA 22.77
EPS(TTM)0.45
EY1.5%
EPS(NY)0.57
Fwd EY1.88%
FCF(TTM)-2
FCFYN/A
OCF(TTM)1.84
OCFY6.13%
SpS9.68
BVpS17.85
TBVpS12.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.65%
ROE -20.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.76%
FCFM N/A
ROA(3y)-1.42%
ROA(5y)4.24%
ROE(3y)-3.13%
ROE(5y)7.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.17%
GM growth 5Y-11.02%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA 6.1
Cap/Depr 176%
Cap/Sales 39.62%
Interest Coverage N/A
Cash Conversion 133.55%
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 0.92
Altman-Z 1.57
F-Score4
WACC10.24%
ROIC/WACCN/A
Cap/Depr(3y)223.59%
Cap/Depr(5y)192.25%
Cap/Sales(3y)44.1%
Cap/Sales(5y)35.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.91%
EPS 3Y-54.95%
EPS 5Y-36.62%
EPS Q2Q%400%
EPS Next Y-73.98%
EPS Next 2Y15.21%
EPS Next 3Y36.39%
EPS Next 5Y41.29%
Revenue 1Y (TTM)-3.72%
Revenue growth 3Y-12.41%
Revenue growth 5Y-5.9%
Sales Q2Q%0.2%
Revenue Next Year-1.21%
Revenue Next 2Y1.04%
Revenue Next 3Y2.22%
Revenue Next 5Y4.51%
EBIT growth 1Y-963.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1300.23%
EBIT Next 3Y182.59%
EBIT Next 5Y96.64%
FCF growth 1Y34.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.34%
OCF growth 3Y-34.47%
OCF growth 5Y-24.21%